Ruosha Li1, Steven H Belle2, Simon Horslen3, Ling-wan Chen4, Song Zhang5, Robert H Squires6. 1. Department of Biostatistics, University of Texas School of Public Health, Houston, TX. 2. Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA. 3. Division of Gastroenterology, Seattle Children's Hospital, Seattle, WA. 4. Department of Statistics, University of Pittsburgh, Pittsburgh, PA. 5. Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA. 6. Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, PA. Electronic address: squiresr@upmc.edu.
Abstract
OBJECTIVE: To investigate the heterogeneity in clinical course among those with pediatric acute liver failure (PALF) of indeterminate disease etiology. STUDY DESIGN: We studied participants enrolled in the PALF registry study with indeterminate final diagnosis. Growth mixture modeling was used to analyze participants' international normalized ratio, total bilirubin, and hepatic encephalopathy trajectories in the first 7 days following enrollment. Participants with at least 3 values for 1 or more of the measurements were included. We examined the association between the resulting latent subgroup classification with participants' characteristics and disease outcomes. Data from participants with PALF of specified etiologies were used to investigate the potential diagnostic value of the latent subgroups. RESULTS: In this sample of 380 participants with indeterminate final diagnosis, 115 (30%) experienced mild and quickly improving disease trajectories and another 48 (13%) started with severe disease but improved by day 7. The majority of participants (216, 57%) had disease trajectories that worsened over time. The identified patterns of disease trajectories are predictive of outcome (P < .001). The trajectory patterns are associated with the underlying disease etiology (P < .001) for the 488 participants with PALF of specified etiologies. CONCLUSIONS: The clinical courses of participants with PALF of indeterminate disease etiology exhibit distinct trajectory patterns, which have important prognostic and potentially diagnostic value.
OBJECTIVE: To investigate the heterogeneity in clinical course among those with pediatric acute liver failure (PALF) of indeterminate disease etiology. STUDY DESIGN: We studied participants enrolled in the PALF registry study with indeterminate final diagnosis. Growth mixture modeling was used to analyze participants' international normalized ratio, total bilirubin, and hepatic encephalopathy trajectories in the first 7 days following enrollment. Participants with at least 3 values for 1 or more of the measurements were included. We examined the association between the resulting latent subgroup classification with participants' characteristics and disease outcomes. Data from participants with PALF of specified etiologies were used to investigate the potential diagnostic value of the latent subgroups. RESULTS: In this sample of 380 participants with indeterminate final diagnosis, 115 (30%) experienced mild and quickly improving disease trajectories and another 48 (13%) started with severe disease but improved by day 7. The majority of participants (216, 57%) had disease trajectories that worsened over time. The identified patterns of disease trajectories are predictive of outcome (P < .001). The trajectory patterns are associated with the underlying disease etiology (P < .001) for the 488 participants with PALF of specified etiologies. CONCLUSIONS: The clinical courses of participants with PALF of indeterminate disease etiology exhibit distinct trajectory patterns, which have important prognostic and potentially diagnostic value.
Authors: Robert H Squires; Benjamin L Shneider; John Bucuvalas; Estella Alonso; Ronald J Sokol; Michael R Narkewicz; Anil Dhawan; Philip Rosenthal; Norberto Rodriguez-Baez; Karen F Murray; Simon Horslen; Martin G Martin; M James Lopez; Humberto Soriano; Brendan M McGuire; Maureen M Jonas; Nada Yazigi; Ross W Shepherd; Kathleen Schwarz; Steven Lobritto; Daniel W Thomas; Joel E Lavine; Saul Karpen; Vicky Ng; Deirdre Kelly; Nancy Simonds; Linda S Hynan Journal: J Pediatr Date: 2006-05 Impact factor: 4.406
Authors: Edwin Liu; Todd MacKenzie; Emily L Dobyns; Chirag R Parikh; Frederick M Karrer; Michael R Narkewicz; Ronald J Sokol Journal: J Hepatol Date: 2005-07-18 Impact factor: 25.083
Authors: Michael R Narkewicz; Dominic Dell Olio; Saul J Karpen; Karen F Murray; Kathy Schwarz; Nada Yazigi; Song Zhang; Steven H Belle; Robert H Squires Journal: J Pediatr Date: 2009-07-29 Impact factor: 4.406
Authors: Brandy R Lu; Jane Gralla; Edwin Liu; Emily L Dobyns; Michael R Narkewicz; Ronald J Sokol Journal: Clin Gastroenterol Hepatol Date: 2008-10 Impact factor: 11.382
Authors: Michael R Narkewicz; Simon Horslen; Regina M Hardison; Benjamin L Shneider; Norberto Rodriguez-Baez; Estella M Alonso; Vicky L Ng; Mike A Leonis; Kathleen M Loomes; David A Rudnick; Philip Rosenthal; Rene Romero; Girish C Subbarao; Ruosha Li; Steven H Belle; Robert H Squires Journal: Clin Gastroenterol Hepatol Date: 2018-04-30 Impact factor: 11.382
Authors: James E Squires; David A Rudnick; Regina M Hardison; Simon Horslen; Vicky L Ng; Estella M Alonso; Steven H Belle; Robert H Squires Journal: Hepatology Date: 2018-11-01 Impact factor: 17.425
Authors: Pier Luigi Calvo; Francesco Tandoi; Tobias B Haak; Andrea Brunati; Michele Pinon; Dominic Dell Olio; Renato Romagnoli; Marco Spada Journal: Ital J Pediatr Date: 2017-09-25 Impact factor: 2.638
Authors: Cindy L Bryce; Chung Chou H Chang; Yi Ren; Jonathan Yabes; Gabriel Zenarosa; Aditya Iyer; Heather Tomko; Robert H Squires; Mark S Roberts Journal: PLoS One Date: 2018-05-31 Impact factor: 3.240
Authors: Scott Warming; Claire Michel; Ary Serpa Neto; Kartik Kishore; Nada Marhoon; Natasha Holmes; Rinaldo Bellomo; Adam Testro; Marie Sinclair; Paul Gow; Stephen Warrillow Journal: BMJ Open Gastroenterol Date: 2022-04
Authors: Willem S Lexmond; Vincent E de Meijer; René Scheenstra; Sander T H Bontemps; Evelien W Duiker; Elisabeth H Schölvinck; Xuewei Zhou; Karin J von Eije; Koen M E M Reyntjens; Henkjan J Verkade; Robert J Porte; Ruben H de Kleine Journal: United European Gastroenterol J Date: 2022-06-30 Impact factor: 6.866